Amlodipine And Valsartan Tablet
Product Images NDC 64380-217

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 64380-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 11)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 11)
A line graph showing the percentage of subjects with systolic blood pressure below 140 mmHg over a baseline range from 140 to 180 mmHg. The graph compares four treatment groups: Valsartan 320 mg, Amlodipine 10 mg, Amlodipine and Valsartan 10/320 mg, and Placebo, with distinct markers for each group.*
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 12)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 12)
A line graph illustrating the percentage of patients with diastolic blood pressure (DBP) under 90 mmHg based on baseline DBP values ranging from 95 to 110 mmHg. The graph compares data for four groups: Valsartan 320 mg, Amlodipine 10 mg, Amlodipine and Valsartan 10/320 mg combination, and placebo. Each group is represented with distinct markers showing decreasing percentages with increasing baseline DBP.*
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 13)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 13)
A line graph showing the percentage of subjects with systolic blood pressure under 130 mmHg against baseline systolic blood pressure (SBP) in mmHg. The graph compares four groups: Valsartan 320 mg, Amlodipine 10 mg, Amlodipine and Valsartan 10/320 mg, and Placebo, each represented by different symbols on the plot.*
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 14)

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 14)
A line chart showing the percentage of diastolic blood pressure (DBP) less than 80 mmHg versus baseline DBP in mmHg. The chart compares effects of Valsartan 320 mg, Amlodipine 10 mg, their combination (Amlodipine and Valsartan 10/320 mg), and placebo, with distinct symbols for each treatment group.*
FDA Label Image

Amlodipine Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 15)

Amlodipine Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 15)
Chemical structure diagram showing the molecular configuration of the active ingredients amlodipine and valsartan, with chemical groups including aromatic rings, chlorine, and sulfonic acid (SO3H) moieties visible in the structure.*
FDA Label Image

Valsartan Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 16)

Valsartan Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 16)
Chemical structure of amlodipine and valsartan active ingredients, showing their molecular arrangement as depicted in the image.*
FDA Label Image

Container Label 5mg/160mg (00cf9c79 C9d7 42a7 9208 404fcee14f11 17)

Container Label 5mg/160mg (00cf9c79 C9d7 42a7 9208 404fcee14f11 17)
A packaging label for Amlodipine and Valsartan Tablets 5 mg/160 mg by Strides Pharma Inc. The label indicates a quantity of 30 tablets and states 'Rx only'. Dosage instructions and storage conditions are included, along with a barcode and the distributor's information.*
FDA Label Image

Image (00cf9c79 C9d7 42a7 9208 404fcee14f11 18)

Image (00cf9c79 C9d7 42a7 9208 404fcee14f11 18)
Label for Amlodipine and Valsartan Tablets 10 mg/160 mg by Strides Pharma Inc. The label includes active ingredient strengths, storage instructions, a barcode, and states the package contains 30 tablets. It highlights the prescription-only status and provides the NDC 64380-215-01.*
FDA Label Image

Image (00cf9c79 C9d7 42a7 9208 404fcee14f11 19)

Image (00cf9c79 C9d7 42a7 9208 404fcee14f11 19)
Label for Amlodipine and Valsartan tablets by Strides Pharma Inc., showing the strength 5 mg/320 mg. The label includes the NDC 64380-216-01, quantity of 30 tablets, and prescription only indication. Additional printed information includes active ingredient amounts, storage instructions, and a barcode with distributor details.*
FDA Label Image

Container Label 10mg/320mg (00cf9c79 C9d7 42a7 9208 404fcee14f11 20)

Container Label 10mg/320mg (00cf9c79 C9d7 42a7 9208 404fcee14f11 20)
Label for Amlodipine and Valsartan tablets, strength 10 mg/320 mg, manufactured by Strides Pharma Inc. The label indicates 30 tablets per package and states 'Rx only.' Dosage form is tablet for oral use. The label includes storage instructions and warnings to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.